FindMyRecallSubscribe
Class I: serious health riskTerminated

Viatris Octreotide Acetate Injection 500 mcg/mL Recall

Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, Fo…

Viatris Inc · Canonsburg, PA

Risk level
Class I
Reported by FDA
Nov 16, 2022
Recall ID
D-0058-2023
Check your lot numberHow we source this data

Summary

Viatris recalled Octreotide Acetate Injection 500 mcg/mL starting Oct 7, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-0058-2023 on Nov 16, 2022. Reason: Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.

Product description

Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).

Lot numbers, UPCs & expiration codes

Lot #: AJ21002, Exp. 03/2024

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0058-2023
Classification
Class I
Status
Terminated
Recall initiated
Oct 7, 2022
FDA report date
Nov 16, 2022
Quantity
22400 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Viatris Inc

Original FDA data

Every field from FDA enforcement report D-0058-2023, exactly as published.

Show all FDA fields
City
Canonsburg
State
PA
Status
Terminated
Country
United States
Event ID
90974
Address
1000 Mylan Blvd
Code information
Lot #: AJ21002, Exp. 03/2024
Postal code
15317-5853
Report date
Nov 16, 2022
Product type
Drugs
Recall number
D-0058-2023
Classification
Class I
Recalling firm
Viatris Inc
Product quantity
22400 syringes
Termination date
Jan 12, 2024
Reason for recall
Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Octreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For Subcutaneous or Intravenous Use, Rx Only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., Made in Italy, NDC: 67457-246-00 (syringe), 67457-246-01 (carton).
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 7, 2022
Initial firm notification
Letter
Center classification date
Nov 8, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0058-2023, published Nov 16, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls